Jazz Pharmaceuticals Plc · NASDAQ:JAZZ
Pearce Samantha sold 6,907 Jazz Pharmaceuticals Plc shares (Form 4)
Traded May 28, 2026 · Filed Jun 1, 2026
On May 28, 2026, Pearce Samantha (EVP, Chief Commercial Officer) sold 6,907 Jazz Pharmaceuticals Plc shares at US$235.41 for US$1.63M, leaving 50,272 shares. Filed Jun 1, 2026 (Form 4).
- Sold
- 6,907 shares
- Price
- US$235.41
- Value
- US$1.63M
- Holding after
- 50,272 shares
- Trading plan
- No
- Role
- EVP, Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 28, 2026 | Ordinary Shares | Option exercise | 6,907 | US$109.45 | 57,179 | Direct |
| May 28, 2026 | Ordinary Shares | Sale | 6,907 | US$235.41 | 50,272 | Direct |
Source
Related
- Jazz Pharmaceuticals Plc
- Pearce Samantha
- Jazz Pharmaceuticals Plc shareholders
- Form 4 · Pearce Samantha · Aug 7, 2026
- Form 4 · Pearce Samantha · Jul 2, 2026
- Form 4 · Gala Renee D · Oct 7, 2026
- Form 4 · Cozadd Bruce C · Oct 5, 2026
- Form 4 · Patil Neena M · Sep 14, 2026
- Form 4 · Gala Renee D · Sep 10, 2026
- Form 4 · Henderson Mary Elizabeth · Sep 10, 2026